These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 35970685)
1. Elevated heart rate as sympathetic biomarker in human obesity. Seravalle G; Facchetti R; Cappellini C; Annaloro A; Gelfi E; Grassi G Nutr Metab Cardiovasc Dis; 2022 Oct; 32(10):2367-2374. PubMed ID: 35970685 [TBL] [Abstract][Full Text] [Related]
2. Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome. Seravalle G; Vanoli J; Molisano C; Merati V; Grassi G Acta Diabetol; 2022 Nov; 59(11):1429-1435. PubMed ID: 35904642 [TBL] [Abstract][Full Text] [Related]
3. Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure. Grassi G; Seravalle G; Vanoli J; Facchetti R; Spaziani D; Mancia G Clin Res Cardiol; 2023 Jan; 112(1):59-67. PubMed ID: 35552503 [TBL] [Abstract][Full Text] [Related]
4. Reliability of heart rate in reflecting cardiac sympathetic overdrive in type 2 diabetes mellitus. Dell'Oro R; Quarti-Trevano F; Ciardullo S; Perseghin G; Mancia G; Grassi G Clin Auton Res; 2024 Aug; 34(4):437-445. PubMed ID: 39037542 [TBL] [Abstract][Full Text] [Related]
5. Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease. Grassi G; Fowler B; Scali B; Rossi F; Motto E; Pieruzzi F; Mancia G J Hypertens; 2022 Aug; 40(8):1530-1536. PubMed ID: 35792492 [TBL] [Abstract][Full Text] [Related]
6. Limited reliability of heart rate as a sympathetic marker in chronic kidney disease. Dell'Oro R; Quarti-Trevano F; Seravalle G; Bertoli S; Lovati C; Mancia G; Grassi G J Hypertens; 2021 Jul; 39(7):1429-1434. PubMed ID: 33394867 [TBL] [Abstract][Full Text] [Related]
7. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. Quarti Trevano F; Seravalle G; Macchiarulo M; Villa P; Valena C; Dell'Oro R; Mancia G; Grassi G J Hypertens; 2017 Aug; 35(8):1685-1690. PubMed ID: 28350577 [TBL] [Abstract][Full Text] [Related]
8. Association Between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers. Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Facchetti R; Mancia G Hypertension; 2020 Aug; 76(2):577-582. PubMed ID: 32594806 [TBL] [Abstract][Full Text] [Related]
9. Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity. Grassi G; Seravalle G; Dell'Oro R; Arenare F; Facchetti R; Mancia G Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):469-75. PubMed ID: 19157817 [TBL] [Abstract][Full Text] [Related]
10. Heart rate as a sympathetic marker during acute adrenergic challenge. Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542 [TBL] [Abstract][Full Text] [Related]
11. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. Grassi G; Dell'Oro R; Facchini A; Quarti Trevano F; Bolla GB; Mancia G J Hypertens; 2004 Dec; 22(12):2363-9. PubMed ID: 15614031 [TBL] [Abstract][Full Text] [Related]